Weller M - Search Results

1

YAP1-fusions in pediatric NF2-wildtype meningioma.

Sievers P, Chiang J, Schrimpf D, Stichel D, Paramasivam N, Sill M, Gayden T, Casalini B, Reuss DE, Dalton J, Pajtler KW, Hänggi D, Herold-Mende C, Rushing E, Korshunov A, Mawrin C, Weller M, Schlesner M, Wick W, Jabado N, Jones DTW, Pfister SM, von Deimling A, Ellison DW, Sahm F. Sievers P, et al. Among authors: weller m. Acta Neuropathol. 2020 Jan;139(1):215-218. doi: 10.1007/s00401-019-02095-9. Epub 2019 Nov 16. Acta Neuropathol. 2020. PMID: 31734728 Free article. No abstract available.

2

BCL-2 promotes migration and invasiveness of human glioma cells.

Wick W, Wagner S, Kerkau S, Dichgans J, Tonn JC, Weller M. Wick W, et al. Among authors: weller m. FEBS Lett. 1998 Dec 4;440(3):419-24. doi: 10.1016/s0014-5793(98)01494-x. FEBS Lett. 1998. PMID: 9872414 Free article.

3

Transforming growth factor-beta and p-21: multiple molecular targets of decorin-mediated suppression of neoplastic growth.

Ständer M, Naumann U, Wick W, Weller M. Ständer M, et al. Among authors: weller m. Cell Tissue Res. 1999 May;296(2):221-7. doi: 10.1007/s004410051283. Cell Tissue Res. 1999. PMID: 10382266 Review.

4

PTEN gene transfer in human malignant glioma: sensitization to irradiation and CD95L-induced apoptosis.

Wick W, Furnari FB, Naumann U, Cavenee WK, Weller M. Wick W, et al. Among authors: weller m. Oncogene. 1999 Jul 8;18(27):3936-43. doi: 10.1038/sj.onc.1202774. Oncogene. 1999. PMID: 10435616

5

Malignant glioma biology: role for TGF-beta in growth, motility, angiogenesis, and immune escape.

Platten M, Wick W, Weller M. Platten M, et al. Among authors: weller m. Microsc Res Tech. 2001 Feb 15;52(4):401-10. doi: 10.1002/1097-0029(20010215)52:4<401::AID-JEMT1025>3.0.CO;2-C. Microsc Res Tech. 2001. PMID: 11170299 Review.

6

Treosulfan chemotherapy for recurrent malignant glioma.

Schmidt F, Wick W, Herrlinger U, Dichgans J, Weller M. Schmidt F, et al. Among authors: weller m. J Neurooncol. 2000 Sep;49(3):231-4. doi: 10.1023/a:1006496831144. J Neurooncol. 2000. PMID: 11212902 Clinical Trial.

7

Sublethal irradiation promotes migration and invasiveness of glioma cells: implications for radiotherapy of human glioblastoma.

Wild-Bode C, Weller M, Rimner A, Dichgans J, Wick W. Wild-Bode C, et al. Among authors: weller m. Cancer Res. 2001 Mar 15;61(6):2744-50. Cancer Res. 2001. PMID: 11289157

8

Molecular determinants of glioma cell migration and invasion.

Wild-Bode C, Weller M, Wick W. Wild-Bode C, et al. Among authors: weller m. J Neurosurg. 2001 Jun;94(6):978-84. doi: 10.3171/jns.2001.94.6.0978. J Neurosurg. 2001. PMID: 11409528

9

Glioma cell invasion: regulation of metalloproteinase activity by TGF-beta.

Wick W, Platten M, Weller M. Wick W, et al. Among authors: weller m. J Neurooncol. 2001 Jun;53(2):177-85. doi: 10.1023/a:1012209518843. J Neurooncol. 2001. PMID: 11716069 Review.

10

Smac agonists sensitize for Apo2L/TRAIL- or anticancer drug-induced apoptosis and induce regression of malignant glioma in vivo.

Fulda S, Wick W, Weller M, Debatin KM. Fulda S, et al. Among authors: weller m. Nat Med. 2002 Aug;8(8):808-15. doi: 10.1038/nm735. Epub 2002 Jul 15. Nat Med. 2002. PMID: 12118245

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,666 results

Search Page